Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus.
Autorzy :
McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri, USA. Weiss D; Your Diabetes Endocrine Nutrition Group, Inc, Mentor, Ohio, USA. Grant M; MannKind Corporation, Westlake Village, California, USA. Jones MC; MannKind Corporation, Westlake Village, California, USA. KendallDM; MannKind Corporation, Westlake Village, California, USA. Hoogwerf BJ; Endocrinology, Diabetes and Metabolism (Emeritus), Cleveland Clinic, Cleveland, Ohio, USA.
Pokaż więcej
Źródło :
Journal of diabetes [J Diabetes] 2021 Feb; Vol. 13 (2), pp. 164-172. Date of Electronic Publication: 2020 Sep 04.
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
Autorzy :
Hoogwerf BJ; Department of Endocrinology, Diabetes, and Metabolism (Emeritus), Cleveland, Ohio. Pantalone KM; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio. Basina M; Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California. Jones MC; MannKind Corporation, Westlake Village, California. Electronic address: . Grant M; MannKind Corporation, Westlake Village, California. KendallDM; MannKind Corporation, Westlake Village, California.
Comprehensive Pulmonary Safety Review of Inhaled Technosphere Insulin in Patients with Diabetes Mellitus.
Autorzy :
McGill JB; Washington University School of Medicine, St Louis, MO, USA. Peters A; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Buse JB; University of North Carolina School of Medicine, Chapel Hill, NC, USA. Steiner S; MannKind Corporation, Westlake Village, CA, USA. Tran T; MannKind Corporation, Westlake Village, CA, USA. Pompilio FM; MannKind Corporation, Westlake Village, CA, USA.; Arcutis Biotherapeutics, Inc, Westlake Village, CA, USA. KendallDM; MannKind Corporation, Westlake Village, CA, USA. .
Hypoglycaemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus.
Autorzy :
Seaquist ER; University of Minnesota, Minneapolis, MN, USA. Blonde L; Ochsner Medical Center, New Orleans, LA, USA. McGill JB; Washington University School of Medicine, St Louis, MO, USA. Heller SR; University of Sheffield, Sheffield, UK. KendallDM; MannKind Corporation, Westlake Village, CA, USA. Bumpass JB; MannKind Corporation, Westlake Village, CA, USA. Pompilio FM; MannKind Corporation, Westlake Village, CA, USA. Grant ML; MannKind Corporation, Westlake Village, CA, USA.
A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy.
Autorzy :
Ray KK; Faculty of Medicine, School of Public Health, Imperial College, London, UK. KendallDM; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana. Zhao Z; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana. Peng X; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana. Caballero AE; Harvard Medical School, Boston, Massachusetts. Polonsky WH; Behavioral Diabetes Institute, San Diego, California. Nordstrom BL; Real-world Evidence, Evidera, Waltham, Massachusetts. Fan L; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana. Curtis BH; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana. Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 May; Vol. 21 (5), pp. 1101-1110. Date of Electronic Publication: 2019 Jan 24.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes.
Autorzy :
Conget I; a Endocrinology and Diabetes Unit , Hospital Clinic I Universitari , Barcelona , Spain. Kirkman MS; b Division of Endocrinology , University of North Carolina , Chapel Hill , NC , USA. Cao D; c Eli Lilly and Company , Indianapolis , IN , USA. Wong M; c Eli Lilly and Company , Indianapolis , IN , USA. Reviriego J; d Eli Lilly and Company , Madrid , Spain. KendallDM; c Eli Lilly and Company , Indianapolis , IN , USA.
Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.
Autorzy :
Lebrec J; Lilly Deutschland GmbH, Bad Homburg, Germany. Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. Chen YF; Eli Lilly and Company, Indianapolis, IN, USA. Reed C; Eli Lilly and Company Limited, Lilly Research Centre, Windlesham, Surrey, UK. . Kahle-Wrobleski K; Eli Lilly and Company, Indianapolis, IN, USA. Hake AM; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. Raskin J; Eli Lilly and Company, Toronto, Canada. Naderali E; Eli Lilly and Company, Lilly House, Basingstoke, Hampshire, UK.; Faculty of Science, Liverpool Hope University, Liverpool, UK. Schuster D; Eli Lilly and Company, Indianapolis, IN, USA. Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA. KendallDM; Eli Lilly and Company, Indianapolis, IN, USA.
Pokaż więcej
Źródło :
BMC geriatrics [BMC Geriatr] 2016 May 03; Vol. 16, pp. 93. Date of Electronic Publication: 2016 May 03.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
Autorzy :
Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. . Cao D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Boye KS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Curtis B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Schuster DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. KendallDM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Ascher-Svanum H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
Autorzy :
Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. . Zagar A; Eli Lilly and Company, Indianapolis, IN, USA. Jiang D; Eli Lilly and Company, Indianapolis, IN, USA. Schuster D; Eli Lilly and Company, Indianapolis, IN, USA. Schmitt H; Eli Lilly Benelux, Brussels, Belgium. Dennehy EB; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA. KendallDM; Eli Lilly and Company, Indianapolis, IN, USA. Raskin J; Eli Lilly and Company, Indianapolis, IN, USA. Heine RJ; Eli Lilly Canada, Toronto, ON, Canada.
Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
Autorzy :
Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. . Cao D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Boye KS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Curtis B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Schuster DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. KendallDM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. Ascher-Svanum H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
Autorzy :
Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. . Zagar A; Eli Lilly and Company, Indianapolis, IN, USA. Jiang D; Eli Lilly and Company, Indianapolis, IN, USA. Schuster D; Eli Lilly and Company, Indianapolis, IN, USA. Schmitt H; Eli Lilly Benelux, Brussels, Belgium. Dennehy EB; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA. KendallDM; Eli Lilly and Company, Indianapolis, IN, USA. Raskin J; Eli Lilly Canada, Toronto, ON, Canada. Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK.
Autorzy :
Valentine WJ; Ossian Health Economics and Communications, Basel, Switzerland. Electronic address: . Curtis BH; Eli Lilly and Company, Indianapolis, IN, USA. Pollock RF; Ossian Health Economics and Communications, Basel, Switzerland. Van Brunt K; Lilly Research Center, Windlesham, Surrey, UK. Paczkowski R; Eli Lilly and Company, Indianapolis, IN, USA. Brändle M; Division of Endocrinology and Diabetes, Kantonsspital St. Gallen, St. Gallen, Switzerland. Boye KS; Eli Lilly and Company, Indianapolis, IN, USA. KendallDM; Eli Lilly and Company, Indianapolis, IN, USA.
Comment on Zhang et Al. Second-line agents for glycemic control for type 2 diabetes: are newer agents better? Diabetes Care 2014;37:1338-1345.
Autorzy :
Bae J; Eli Lilly and Company, Indianapolis, IN. Curtis BH; Eli Lilly and Company, Indianapolis, IN . KendallDM; Eli Lilly and Company, Indianapolis, IN. Heine RJ; Eli Lilly and Company, Indianapolis, IN.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. e204.
Frederick C. Goetz, MD: a profile of the intersection among science, the fine arts, and education.
Autorzy :
Hoogwerf BJ; Eli Lilly and Co., Indianapolis, IN . KendallDM; Eli Lilly and Co., Indianapolis, IN University of Minnesota, Minneapolis, MN. Seaquist ER; University of Minnesota, Minneapolis, MN.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. 2419-23.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
W koszyku znajdują się zamówienia
W koszyku znajdują się zamówienia do wysłania. Czy chcesz wysłać je do realizacji?
